Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was [...]
Enhertu Breast Cancer Drug Results in ‘Unheard-of’ Survival Rates
For some patients with metastatic tumors not significantly affected by [...]
Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations
The drug, Aduhelm, brought in $300,000 in revenue in its [...]
Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients
The rejection of the new Alzheimer’s drug by the two [...]